Tamoxifen, on the other hand, is an ERα antagonist classified as a non-steroidal selective estrogen receptor modulator (SERM), widely used in cancer chemoprevention and chemotherapy to prevent primary breast tumors or the development of recurrences, respectively [26-28]. Here, ESR1 is linked to breast neoplasm.